A review by Nishibori et al. illustrates that administration of anti-HMGB1 monoclonal antibodies inhibits Dneuronal loss in a 6-OHDA rat model of PD by suppressing ROS production and neuroinflammation (Nishibori et al., 2019). The gene discussed is HMGB1; the disease is Parkinson disease.